Heartseed株式会社
7 known investors
Heartseed develops cardiac regenerative medicine, creating heart muscle cells from iPS cells for transplantation to treat heart failure, with its lead pipeline HS-001 nearing clinical trials. The company targets patients with heart failure caused by conditions such as myocardial infarction, with reference markets in Japan and the US.
Founders & leadership
KF
Keiichi Fukuda代表取締役社長 (President & CEO)
Investors · 7
Angel Bridge Co.,Ltd.Tokyo · $792K – $62M
Astellas Venture Management LLCSouth San Francisco · $200K – $5M
Keio Innovation InitiativeTokyo · $1.5M – $64M
Medical Incubator Japan K.K.Tokyo
SMBC Venture CapitalTokyo · $2.3M – $269Mvia Hiroya Ota · inferred
Sumitomo Mitsui Trust nvestment Co. Ltd.Tokyo
UTokyo Innovation Platform Co. Ltd.Tokyo
Frequently asked questions
- What does Heartseed株式会社 do?
- Heartseed develops cardiac regenerative medicine, creating heart muscle cells from iPS cells for transplantation to treat heart failure, with its lead pipeline HS-001 nearing clinical trials. The company targets patients with heart failure caused by conditions such as myocardial infarction, with reference markets in Japan and the US.
- Who founded Heartseed株式会社?
- Heartseed株式会社 was founded by Keiichi Fukuda.
- Who are Heartseed株式会社's investors?
- Heartseed株式会社's investors include Angel Bridge Co.,Ltd., Astellas Venture Management LLC, Keio Innovation Initiative, Medical Incubator Japan K.K., SMBC Venture Capital, Sumitomo Mitsui Trust nvestment Co. Ltd., UTokyo Innovation Platform Co. Ltd..